Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1996-07-22
1998-06-16
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514725, A61K 3119, A61K 3107
Patent
active
057671559
ABSTRACT:
A method of suppressing ventricular muscle cell hypertrophy induced by an .alpha..sub.1 -adrenergic agonist or endothelin, by providing an effective amount of a retinoic acid compound. Also provided are methods for identifying compounds which suppress ventricular muscle cell hypertrophy, compounds which inhibit the retinoic acid suppression of ventricular muscle cell hypertrophy, and therapeutic methods.
REFERENCES:
patent: 5344644 (1994-09-01), Igari et al.
Monge, J.C. et al., (1995) "Differentiation of Embryonal Carcinoma Cells to a Neural or cariomyocytes Lineage Is Associated with Selective Expression of Endothelin Receptors", J. Biol. Chem. 270(25):15385-90.
Zhou et al., Retinoid-dependent pathways suppress myocardial cell hypertrophy, 1995.
Argentin, Stefania, et al., "Distal cis-Acting Promoter Sequences Mediate Glucocorticoid Stimulation of Cardiac Atrial Natriuetic Factor Gene Transcription," J. Biol. Chem., (Dec. 5 1991) vol. 266, No. 34, pp. 23315-23322.
Argentin, Stefania, et al., "The Gene for Rat Atrial Natriuetic Factor," J. Biol. Chem., (Apr. 25, 1985), vol. 260, No. 8, pp. 4568-4571.
Battistini, Bruno, et al., "Growth Regulatory Properties of Endothelins," Peptides, (1993) vol. 14, pp. 385-399.
Buttrick, Peter, et al., "Effects of chronic dobutamine on cardiac mechanics and biochemistry after myocardial infarction in rats," Am. J. Phyisol. (1991), pp. H473-H479.
Cherrington, Julie M., et al., "Human Cytomegalovirus ie1 Transactivates the .alpha. Promoter-Enhancer via an 18-Base-Pair Repeat Element" J. Virol. (Mar. 1989), vol. 63, No. 3, pp. 1435-1440.
Chien, Kenneth R., et al., "Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response," FASEB, Dec. 1991, vol. 5, pp. 3037-3046.
Chirgwin, John M., et al., "Isolation of Biologically Active Ribonucleic Acid from Sources Enriched in Ribonuclease," Biochemistry, (1979) vol. 18, No. 24, pp. 5294-5299.
Cox, Lydia R., et al., "Effects of retinoic acid on NIH3T3 cell transformation by the H-ras oncogene," J. Cancer Res. Clin. Oncol., (1991) vol. 117, pp. 102-108.
Damm, Klaus, et al., "Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants," Proc. Natl. Acad. Sci, USA, (Apr. 1993) vol. 90, pp. 2989-2993.
De Wet, Jeffrey R., et al., "Firefly Luciferase Gene: Structure and Expression in Mammalian Cells," Mol. Cell. Biol., (Feb. 1987) vol. 7, No. 2, pp. 725-737.
Dyson, E. et al., "Atrial-like Phenotype Is Associated With Embryonic Ventricular Failure In Retinold X Receptor .alpha. -/-mice" Proc. Natl. Acad. Sci. USA, (Aug. 1995) vol. 92, pp. 7386-7390.
Evans, Ronald, M., "The Steroid and Thyroid Hormone Receptor Superfamily," Science, (May 13, 1988) vol. 240, pp. 889-895.
Geenen, David L., "Papillary mechanics and cardiac morphology of infarcted rat hearts after training," J. Appl. Physiol. (1987) pp. 92-96.
Giguere, Vincent, et al., "Identification of a Novel Isoform of the Retinoic Acid Receptor .gamma. Expressed in the Mouse Embryo," Mol. Cell. Biol. (May 1990) vol. 10, No. 5, pp. 2335-2340.
Giguere, Vincent, et al., "Identification of a receptor for the morphogen retinoic acid," Nature, (Dec. 17, 1987), vol. 330, pp. 624-629.
Glembotski, Christopher C., "The Characterization of Atrial Natriuretic Peptide (ANP) Expression by Primary Cultures of Atrial Myocytes Using an ANP-Specific Monoclonal Antibody and an ANP Messenger Ribonucleic Acid Probe", Endocrinology, (1987) vol. 121, No. 3, pp. 843-852.
Gossett, Lani A., et al., "A New Myocyte-Specific Enhancer-Binding Factor That Recognizes a Conserved Element Associated with Multiple Muscle-Specific Genes," Mol. Cel. Biol., (Nov. 1989) vol. 9, No. 11, pp. 5022-5033.
Grepin, Claudine, et al., "A Hormone-Encoding Gene Identifies a Pathway for Cardiac but Not Skeletal Muscle Gene Transcription," Mol. Cell. Biol., (May 1994) vol. 14, No. 5, pp. 3115-3129.
Hermann, Thomas, et al., "Heterodimetic Receptor Complexes Determine 3,5,3'-Triiodothyronine and Retinoid Signaling Specificities," Mol. Endocrinol., (1992) vol. 6, No. 7, pp. 1153-1162.
Heyman, Richard A., et al., "9-Cis Retinoic Acid is a High Affinity Ligand for the Retinoid X Receptor," Cell, (Jan. 24, 1992), vol. 68, pp. 397-406.
Hilal-Dandan, Randa, et al., "Coupling of the Type A Endothelin Receptor to Multiple Responses in Adult Rat Cardiac Myocytes," Mol. Pharm., (1994) vol. 45, pp. 1183-1190.
Ihara, Masaki, et al., "Biological Profiles of Highly Potent Novel Endothelin Antagonists Selective for the ET.sub.A Receptor," Life Sciences, (1992) vol. 50, No. 4, pp. 247-255.
Inoue, Akihiro, et al., "The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes," Proc. Natl. Acad. Sci. USA, (Apr. 1989) vol. 86, pp. 2863-2867.
Ito, Hiroshi, et al., "Endothelin-1 Induces Hypertrophy With Enhanced Expression of Muscle-Specific Genes in Cultured Neonatal Rat Cardiomyocytes," Circ. Res., (Jul. 1991) vol. 69, No. 1, pp. 209-215.
Jones, Linda G., et al., "Endothelin stimulates multiple responses in isolated adult ventricular cardiac myocytes," Am. J. Physiol., (11992) vol. 263, pp. H1447-H1454.
Jong, Ling et al., "Conformational Effects on Retinoid Receptor Selectivity, 1. Effect of a 9-Double Bond Geometry on Retinoid X Receptor Activity," J. Med. Chem., (1993) vol. 36, pp. 2605-2613.
Kelly, Tamsin Lisa, et al., "Prediction of outcome in late-stage cardiomyopathy," Amer. Heart J. (May 1990) vol. 119, No. 5; pp. 1111-1121.
Knowlton, Kirk U., et al., "Co-regulation of the Atrial Natriuetic Factor and Cardiac Myosin Light Chain-2 Genes during .alpha.-Adrenergic Stimulation of Neonatal Rat Ventricular Cells," J. Biol. Chem., (Apr. 25, 1991) vol. 266, No. 12, pp. 7759-7768.
Knowlton, Kirk U., et al., "The .alpha..sub.1A -Adrenergic Receptor Subtype Mediates Biochemical, Molecular, and Morphologic Features of Cultured Myocardial Cell Hypertrophy," J. Biol. Chem., (Jul. 25, 1993) vol. 268, No. 21, pp. 15374-15380.
Kloner, Robert A., et al., "The effect of early exercise on myocardial infarct scar formation," Amer. Heart J. (Nov. 1983) vol. 106, No. 5, pp. 1009-1013.
Kumar, C. Chandra, et al., "Heart Myosin Light Chain 2 Gene," J. Biol. Chem., (Feb. 25, 1986) vol. 261, No. 6, pp. 2866-2872.
LaMorte, Vicki J., et al., "G.sub.q -and Ras-dependent Pathways Mediate Hypertrophy of Neonatal Rat Ventricular Myocytes following .alpha..sub.1 -Adrenergic Stimulation," J. Biol. Chem. (May 6, 1994) vol. 269, No. 18, pp. 13490-13496.
Leder, Aya, et al., "v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retonoic acid," Proc. Natl. Acad. Sci. USA (Dec. 1990), vol. 87, pp. 9178-9182.
Mangelsdorf, David J., et al., "Nuclear receptor that identifies a novel retinoic acid response pathway," Nature (May 17, 1990), vol. 345, pp. 224-229.
Mangelsdorf, David J., et al., "A Direct Repeat in the Cellular Retinol-Binding Protein Type II Gene Confers Differential Regulation by RXR and RAR;" Cell (Aug. 9, 1991), vol. 66, pp. 555-561.
Mangelsdorf, David J., et al., "Characterization of three RXR genes that mediate the action of 9-cis retinoic acid," Genes & Dev. (1992) vol. 6, pp. 329-344.
Rohrer, Daniel K., et al., "Influence of Thyroid Hormone and Retinoic Acid on Slow Sarcoplasmic Reticulum Ca.sup.2+ ATPase and Myosin Heavy Chain .alpha. Gene Expression in Cardiac Myocytes," J. Biol. Chem., (May 5, 1991) vol. 266, No. 13, pp. 8638-8646.
Rosenthal, Nadia, "Identification of Regulatory Elements of Cloned Genes with Functional Assays," Methods Enzymol. (1987) vol. 152, pp. 704-720.
Salbert, Gilles, et al., "Retinoic Acid Receptors and Retinoid X Receptor-.alpha. Down-Regulate the Transforming Growth Factor-.beta..sub.1 Promoter by Antagonizing AP-1 Activity," Molec. Endocrinol. (1993) vol. 7, No. 10, pp. 1347-1356.
Schule, Roland, et al., "Retinoic acid is a negative regulator of AP-1-responsive genes," Proc. Natl. Acad. Sci. USA, (Jul. 1991) vol. 88, pp. 6092-6096.
Shubeita, Huda E., et al., "Endothelin Induction of Inositol
Chien Kenneth R.
Zhou Ming Dong
Francis Carol L.
The Regents of the University of California
Weddington Kevin E.
LandOfFree
Retinoid suppression of ventricular muscle cell hypertrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Retinoid suppression of ventricular muscle cell hypertrophy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retinoid suppression of ventricular muscle cell hypertrophy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726493